TOKYO, March 28 | Wed Mar 28, 2012 10:22pm EDT
TOKYO, March 28 (Reuters) - Pfizer Inc said on Thursday that it has agreed to license Astellas Pharma Inc to make and sell its Lipitor cholesterol drug in Japan to March 2021, extending the term of the previous agreement by five years.
0 comments:
Post a Comment